NewGene Plans to Offer 454-Based Genetic Testing for UK's NHS, Other Clients by Early 2010

The company expects to use Roche's 454 technology to offer full-gene sequencing tests at a lower cost and faster turnaround time than existing providers using Sanger sequencing.

Full-text access for premium subscribers only. Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.